Results 251 to 260 of about 10,002,415 (357)
This work reports conceptually unprecedented topological quantum biomaterials derived from engineered Pd3Sn nanostrips for oncological applications. Their near‐Fermi‐level electronic architecture and superior interfacial charge transport facilitate ultrasound‐amplified redox reactions and efficient ROS generation.
Zilu Chen +10 more
wiley +1 more source
Secondary intraocular extranodal natural killer/T-cell lymphoma with optic nerve involvement: a case report. [PDF]
Ersan S +7 more
europepmc +1 more source
A self‐amplifying bio‐clay nanozyme (Bio‐Clayzyme) disrupts tumor metabolic homeostasis through endogenous copper transporter ATPase (ATP7A) downregulation, enhancing cascade catalysis and triggering immunogenic pyroptosis for effective tumor immunotherapy.
Weimin Xie +4 more
wiley +1 more source
Genetic Variation Underlying CSF Natural Killer T-Cell Frequency in Inflammatory CNS Diseases: A Genome-Wide Association Study. [PDF]
Wirsching L +11 more
europepmc +1 more source
This study reveals that large tumors secrete more chemokine CXCL3, which recruits immunosuppressive neutrophils to the periphery, thereby impairing the activation and memory of systemic tumor‑reactive CD8+ T cells. CXCL3 antagonism restores systemic immune memory and enhances the antitumor efficacy of anti‑PD‑1 therapy, offering a potential strategy to
Ji Wang +15 more
wiley +1 more source
Harnessing Natural Killer Cells: From Neuroimmunology to Novel Therapies for Central Nervous System Diseases. [PDF]
Deng K, Chong WP.
europepmc +1 more source
This study generates the single‐cell atlas of pathogenic B‐cell subset Bc‐5 in ITP. It identifies RUNX3 as a key survival regulator and uncovers sphingolipid‐driven metabolic reprogramming, validating UGCG inhibition as a therapeutic candidate and building a valuable resource for ITP mechanistic and therapeutic exploration.
Dongmei Luo +10 more
wiley +1 more source
Natural Killer Cell Plasticity in Epithelial Ovarian Cancer and Their Therapeutic Implications. [PDF]
Onuma T +3 more
europepmc +1 more source
A dual‐transmembrane Bicephali CAR‐T platform simultaneously targets CD276 and NKG2D ligands to address antigen heterogeneity in non‐small cell lung cancer. By improving immune synapse formation, mitochondrial fitness, antioxidant capacity, and stem‐like persistence, this design enhances durable tumor control and provides a versatile strategy to ...
Lina Wang +8 more
wiley +1 more source
Advances in natural killer cell immunotherapy for hematologic malignancies. [PDF]
Hu H, Xiong Y, Xia M, Sheng L.
europepmc +1 more source

